Deep Track Capital, Lp Top Holdings and 13F Report (2025) About Deep Track Capital, LpInvestment ActivityDeep Track Capital, Lp has $2.68 billion in total holdings as of December 31, 2024.Deep Track Capital, Lp owns shares of 62 different stocks, but just 26 companies or ETFs make up 80% of its holdings.Approximately 29.82% of the portfolio was purchased this quarter.About 42.37% of the portfolio was sold this quarter.This quarter, Deep Track Capital, Lp has purchased 69 new stocks and bought additional shares in 17 stocks.Deep Track Capital, Lp sold shares of 20 stocks and completely divested from 22 stocks this quarter.Largest Holdings Dynavax Technologies $227,197,276Guardant Health $196,117,741Intra-Cellular Therapies $167,040,000Immunovant $148,620,000Apellis Pharmaceuticals $136,412,729 Largest New Holdings this Quarter Harmony Biosciences $49,894,500 HoldingSEPTERNA INC $43,806,074 HoldingGenmab A/S $41,740,000 HoldingCelldex Therapeutics $38,919,136 HoldingProtagonist Therapeutics $38,600,000 Holding Largest Purchases this Quarter Cytokinetics 1,870,094 shares (about $87.97M)Dynavax Technologies 5,265,000 shares (about $67.23M)Harmony Biosciences 1,450,000 shares (about $49.89M)NEUMORA THERAPEUTICS INC. 4,441,872 shares (about $47.08M)SEPTERNA INC 1,912,929 shares (about $43.81M) Largest Sales this Quarter Verona Pharma 2,330,025 shares (about $108.21M)Bicycle Therapeutics 2,271,920 shares (about $31.81M)DYNE THERAPEUTICS INC 1,282,000 shares (about $30.20M)Mind Medicine (MindMed) 4,248,505 shares (about $29.57M)4D Molecular Therapeutics 3,486,552 shares (about $19.42M) Sector Allocation Over TimeMap of 500 Largest Holdings ofDeep Track Capital, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorDVAXDynavax Technologies$227,197,276$67,234,050 ▲42.0%17,791,4868.5%MedicalGHGuardant Health$196,117,741$12,800,633 ▲7.0%6,419,5667.3%MedicalITCIIntra-Cellular Therapies$167,040,000$33,350,121 ▲24.9%2,000,0006.2%MedicalIMVTImmunovant$148,620,000$40,933,317 ▲38.0%6,000,0005.5%MedicalAPLSApellis Pharmaceuticals$136,412,729$4,012,140 ▼-2.9%4,274,9215.1%MedicalSWTXSpringWorks Therapeutics$125,037,114$13,842,993 ▼-10.0%3,460,7564.7%MedicalCYTKCytokinetics$117,600,000$87,969,222 ▲296.9%2,500,0004.4%MedicalOCULOcular Therapeutix$109,621,848$980,580 ▲0.9%12,836,2824.1%MedicalVRDNViridian Therapeutics$86,700,945$14,795,329 ▲20.6%4,522,7413.2%MedicalPLRXPliant Therapeutics$78,654,6250.0%5,972,2572.9%MedicalGPCRStructure Therapeutics$75,936,000$42,835,823 ▲129.4%2,800,0002.8%MedicalIONSIonis Pharmaceuticals$67,610,123$9,301,877 ▼-12.1%1,933,9282.5%MedicalNRIXNurix Therapeutics$56,520,000$16,355,079 ▼-22.4%3,000,0002.1%MedicalMBX BIOSCIENCES INC$55,638,9720.0%3,018,9352.1%COMNEUMORA THERAPEUTICS INC.$55,011,880$47,083,843 ▲593.9%5,189,8002.1%COMETNB89bio$50,659,907$29,025,783 ▲134.2%6,478,2491.9%MedicalHRMYHarmony Biosciences$49,894,500$49,894,500 ▲New Holding1,450,0001.9%MedicalDYNE THERAPEUTICS INC$47,120,000$30,203,920 ▼-39.1%2,000,0001.8%COMSEPTERNA INC$43,806,074$43,806,074 ▲New Holding1,912,9291.6%COMGMABGenmab A/S$41,740,000$41,740,000 ▲New Holding2,000,0001.6%MedicalAKROAkero Therapeutics$41,451,800$22,262,009 ▲116.0%1,490,0001.5%MedicalVRNAVerona Pharma$39,474,000$108,206,361 ▼-73.3%850,0001.5%MedicalCLDXCelldex Therapeutics$38,919,136$38,919,136 ▲New Holding1,540,1321.5%MedicalPTGXProtagonist Therapeutics$38,600,000$38,600,000 ▲New Holding1,000,0001.4%MedicalANIPANI Pharmaceuticals$35,879,042$7,972,150 ▲28.6%649,0421.3%MedicalBICARA THERAPEUTICS INC$34,840,000$20,958,838 ▲151.0%2,000,0001.3%COMAUTLAutolus Therapeutics$33,414,422$2,475,182 ▼-6.9%14,218,9031.2%MedicalKORRO BIO INC$33,296,555$937,055 ▲2.9%874,6141.2%COMTERNTerns Pharmaceuticals$30,894,1310.0%5,576,5581.2%MedicalENGENE HOLDINGS INC$30,307,874$12,967,114 ▲74.8%4,557,5751.1%COMRAREUltragenyx Pharmaceutical$27,493,292$27,493,292 ▲New Holding653,5131.0%MedicalABIVAX SA$26,199,8100.0%3,579,2091.0%SPONSORED ADSCNTACentessa Pharmaceuticals$22,612,5000.0%1,350,0000.8%MedicalBBIOBridgeBio Pharma$22,477,805$22,477,805 ▲New Holding819,1620.8%MedicalGLPGGalapagos$21,471,395$21,471,395 ▲New Holding780,7780.8%MedicalOLMAOlema Pharmaceuticals$20,071,716$3,248,284 ▼-13.9%3,442,8330.7%MedicalMNMDMind Medicine (MindMed)$19,603,494$29,569,594 ▼-60.1%2,816,5940.7%MedicalEWTXEdgewise Therapeutics$18,968,241$10,416,071 ▼-35.4%710,4210.7%MedicalBCYCBicycle Therapeutics$17,865,134$31,806,880 ▼-64.0%1,276,0810.7%MedicalUPSTREAM BIO INC$16,440,000$16,440,000 ▲New Holding1,000,0000.6%COMNVAXNovavax$16,080,000$16,080,000 ▲New Holding2,000,0000.6%MedicalIMCRImmunocore$15,321,592$15,321,592 ▲New Holding519,3760.6%MedicalORUKA THERAPEUTICS INC$14,542,500$9,407,776 ▼-39.3%750,0000.5%COMGERNGeron$14,199,956$12,615,717 ▼-47.0%4,011,2870.5%MedicalCYBIN INC$13,494,4850.0%1,529,9870.5%COM NEWXNCRXencor$11,490,000$6,894,000 ▼-37.5%500,0000.4%MedicalALIGOS THERAPEUTICS INC$9,725,3420.0%244,1100.4%COM NEWRAPTRAPT Therapeutics$9,497,980$9,497,980 ▲New Holding6,011,3800.4%MedicalZURAZura Bio$8,209,4580.0%3,283,7830.3%MedicalCNTXContext Therapeutics$7,790,3230.0%7,419,3550.3%MedicalALLKAllakos$6,902,181$852,181 ▲14.1%5,704,2820.3%MedicalXENEXenon Pharmaceuticals$6,629,974$6,629,974 ▲New Holding169,1320.2%MedicalAVALO THERAPEUTICS INC$6,441,810$743,000 ▼-10.3%867,0000.2%COM NEWINOVIO PHARMACEUTICALS INC$5,708,066$2,406,076 ▲72.9%3,119,1620.2%COM SHSRGLSRegulus Therapeutics$5,154,8510.0%3,262,5640.2%MedicalSPYRE THERAPEUTICS INC$5,098,669$18,181,330 ▼-78.1%219,0150.2%COM NEWIVVDInvivyd$4,736,563$117,126 ▼-2.4%10,689,6030.2%MedicalONKURE THERAPEUTICS INC$4,506,305$4,506,305 ▲New Holding523,9890.2%COM CL AFDMT4D Molecular Therapeutics$3,397,143$19,420,095 ▼-85.1%609,9000.1%MedicalELYMEliem Therapeutics$1,872,207$2,032,250 ▼-52.0%1,040,1150.1%MedicalNKTRNektar Therapeutics$1,837,678$12,970,390 ▼-87.6%1,975,9980.1%MedicalSAVACassava Sciences$1,180,000$1,180,000 ▲New Holding500,0000.0%MedicalARGXargenx$0$197,859,200 ▼-100.0%00.0%MedicalNTLAIntellia Therapeutics$0$101,722,500 ▼-100.0%00.0%MedicalALKSAlkermes$0$97,965,000 ▼-100.0%00.0%MedicalAXSMAxsome Therapeutics$0$95,012,272 ▼-100.0%00.0%MedicalAPOGEE THERAPEUTICS INC$0$58,740,000 ▼-100.0%00.0%COMTGTXTG Therapeutics$0$40,347,750 ▼-100.0%00.0%MedicalKURAKura Oncology$0$38,366,888 ▼-100.0%00.0%MedicalKYMRKymera Therapeutics$0$28,413,430 ▼-100.0%00.0%MedicalRNAAvidity Biosciences$0$21,816,750 ▼-100.0%00.0%MedicalALECAlector$0$21,585,111 ▼-100.0%00.0%MedicalFATEFate Therapeutics$0$19,504,125 ▼-100.0%00.0%MedicalSLNSilence Therapeutics$0$18,180,000 ▼-100.0%00.0%MedicalEDITEditas Medicine$0$16,710,139 ▼-100.0%00.0%MedicalPYXSPyxis Oncology$0$15,355,647 ▼-100.0%00.0%MedicalTVTXTravere Therapeutics$0$7,440,679 ▼-100.0%00.0%MedicalVIGLVigil Neuroscience$0$5,283,586 ▼-100.0%00.0%MedicalALTO NEUROSCIENCE INC$0$2,512,773 ▼-100.0%00.0%COM SHSPRTAProthena$0$2,342,200 ▼-100.0%00.0%MedicalRLMDRelmada Therapeutics$0$2,186,459 ▼-100.0%00.0%MedicalSYRSSyros Pharmaceuticals$0$1,781,243 ▼-100.0%00.0%MedicalMETAGENOMI INC$0$667,275 ▼-100.0%00.0%COMSRRKScholar Rock$0$385,281 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
